Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study

Schmidt, Andrew; Bakouny, Ziad; Bhalla, Sheena; Steinharter, John A.; Tremblay, Douglas; Awad, Mark M.; Kessler, Alaina J.; Haddad, Robert I.; Evans, Michelle V.; Busser, Fiona; Wotman, Michael; Curran, Catherine; Zimmerman, Brittney S.; Bouchard, Gabrielle; Jun, Tomi; Nuzzo, Pier Vitale; Qin, Qian; Hirsch, Laure; Feld, Jonathan; Kelleher, Kaitlin M.; Seidman, Danielle; Huang, Hsin-Hui; Anderson-Keightly, Heather; Alaiwi, Sarah Abou; Rosenbloom, Talia D.; Stewart, Penina S.; Galsky, Matthew D.; Choueiri, Toni K.; Doroshow, Deborah Blythe

doi:10.1016/j.ccell.2020.10.023

Cited by 61 publications

(59 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“… [1] , [2] , [3] , [4] This population is particularly susceptible to COVID-19 given their older age, smoking history, and pre-existing cardiopulmonary comorbidities. In many occurrences, as we previously reported, [5] the pandemic has resulted in significant disruption in cancer care, including decreased in-person visits, increased telehealth visits, and delays in treatment. The goal of this study was to evaluate the disruption to care of patients with LC during the COVID-19 pandemic.…”

Section: Introductionmentioning

confidence: 57%

Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study

et al. 2021

Self Cite

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

Section: Introductionmentioning

confidence: 57%

Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…The sustainability of these regulatory changes is essential to long-term telemedicine integration. 30 How to optimize telehealth approaches to assure access to a similar quality of telemedicine care and discerning the right balance between in-person and televisits are essential research questions that remain. In addition, ongoing data collection of the identified predictive at-risk factors will be necessary (e.g., race, ethnicity, age, sex, geography, income [socioeconomic status], education, language, culture, literacy, and digital literacy) to assess improvements and impact on outcome.…”

Section: Practical Applicationsmentioning

confidence: 99%

Barriers and Facilitators to Telemedicine: Can You Hear Me Now?

López

Lam

Thota

2021

American Society of Clinical Oncology Educational Book

111

View full text Add to dashboard Cite

In its most direct interpretation, telemedicine is medical care provided at a distance. Although telemedicine’s use had been steadily increasing, the COVID-19 pandemic prompted an unprecedented interest and urgency among patients, health care professionals, and policymakers to facilitate health care devoid of the need for in-person contact. The growth in personal access to telecommunications technology meant an unprecedented number of people in the United States and around the world had access to the equipment and technology that would make virtual care possible from the home. As the mass implementation of telemedicine unfolded, it became quickly apparent that scaling up the use of telemedicine presented considerable new challenges, some of which worsened disparities. This article describes those challenges by examining the history of telemedicine, its role in both supporting access and creating new barriers to access in trying to get everyone connected, frameworks for thinking about those barriers, and facilitators that may help overcome them, with a particular focus on older adults and patients with cancer in rural communities.

show abstract

“…COVID-19 has caused substantial global delays in cancer care, including delays in cancer screening as well as an anticipated increase in cancer-related deaths even among patients who did not develop COVID-19 infection. (11)(12)(13)(14) Optimization of precautions and clearance guidelines is therefore essential for improving the care of cancer patients both with and without COVID-19.…”

Section: Days Since Diagnostic Rt-pcr Positive Assaymentioning

confidence: 99%